A strong interferon response correlates with a milder dengue clinical condition

Journal of Clinical Virology

Volumn 60, Issue 3, 2014, Pages 196-199

  De La Cruz Hernández, Sergio Isaac ^a   Puerta Guardo, Henry ^a,b   Flores Aguilar, Hilario ^a   González Mateos, Silvia ^a   López Martinez, Irma ^a   Ortiz Navarrete, Vianney ^a   Ludert, Juan E ^a   Del Angel, Rosa María ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dengue; Dengue diagnostic; Dengue patient sera; Interferon

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; VIRUS ANTIBODY;

ARTICLE; ASSAY; CONTROLLED STUDY; CYTOMETRY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; FEVER; HUMAN; MAJOR CLINICAL STUDY; PRIMARY INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY INFECTION; SEROTYPE; WORLD HEALTH ORGANIZATION; BLOOD; CASE CONTROL STUDY; DENGUE VIRUS; GENETICS; GENOTYPE; IMMUNOLOGY; SEVERE DENGUE; SEVERITY OF ILLNESS INDEX; TIME;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; DENGUE; DENGUE VIRUS; GENOTYPE; HUMANS; INTERFERON-ALPHA; INTERFERONS; SEVERE DENGUE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84902180563     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.04.002     Document Type: Article

References (24)

1. Guha-Sapir D., Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2005, 2(1):1.
2. Noisakran S., Perng G.C. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Exp Biol Med (Maywood) 2008, 233(4):401-408.
3. Martina B.E., Koraka P., Osterhaus A.D. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009, 22(4):564-581.
4. Clyde K., Kyle J.L., Harris E. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 2006, 80(23):11418-11431.
5. Halstead S.B. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 2003, 60:421-467.
6. Halstead S.B., O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977, 265(5596):739-741.
7. Brandt W.E., et al. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun 1982, 36(3):1036-1041.
8. Puerta-Guardo H., et al. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. J Virol 2013, 87(13):7486-7501.
9. Garcia-Sastre A., Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312(5775):879-882.
10. Pitha P.M., Kunzi M.S. Type I interferon: the ever unfolding story. Curr Top Microbiol Immunol 2007, 316:41-70.
11. Munoz-Jordan J.L., et al. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA 2003, 100(24):14333-14338.
12. Munoz-Jordan J.L., Fredericksen B.L. How flaviviruses activate and suppress the interferon response. Viruses 2010, 2(2):676-691.
13. Aguirre S., et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 2012, 8(10):e1002934.
14. Morrison J., et al. Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS Pathog 2013, 9(3):e1003265.
15. Pagni S., Fernandez-Sesma A. Evasion of the human innate immune system by dengue virus. Immunol Res 2012, 54(1-3):152-159.
16. Rodriguez-Madoz J.R., et al. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 2010, 84(19):9760-9774.
17. Rodriguez-Madoz J.R., et al. Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 2010, 84(9):4845-4850.
18. de la Cruz-Hernandez S.I., et al. Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico. Am J Trop Med Hyg 2013, 88(3):446-454.
19. De La Cruz Hernandez S.I., et al. Viral load in patients infected with dengue is modulated by the presence of anti-dengue IgM antibodies. J Clin Virol 2013, 58(1):258-261.
20. Ahmed F., et al. Evaluation of ASSURE(R) dengue IgA rapid test using dengue-positive and dengue-negative samples. Diagn Microbiol Infect Dis 2010, 68(4):339-344.
21. Chen R.F., et al. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans R Soc Trop Med Hyg 2007, 101(11):1106-1113.
22. Tang Y., et al. Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS ONE 2010, 5(12):e15631.
23. Gandini M., et al. Dengue virus activates membrane TRAIL relocalization and IFN-alpha production by human plasmacytoid dendritic cells in vitro and in vivo. PLoS Negl Trop Dis 2013, 7(6):e2257.
24. Kurane I., et al. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg 1993, 48(2):222-229.